Whiteboard Doctor | August 1, 2020
WhiteBoard style discussion on a study in pre-print looking at dual histamine blockers (pepcid or famotidine and zyrtec or cetirizine) in the treatment of COVID-19. They compared patients with standard of care versus those who received these two antihistamine medications and looked at inpatient outcomes with positive results.
Be the First to Know
Sign up to get updates when we add new off-label treatments, articles, videos, and clinical trials!